Search: onr:"swepub:oai:lup.lub.lu.se:484926ba-dd23-4a76-8940-f93fd81d5123" > Confirmation of the...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03674naa a2200481 4500 | |
001 | oai:lup.lub.lu.se:484926ba-dd23-4a76-8940-f93fd81d5123 | |
003 | SwePub | |
008 | 160404s2016 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/88562692 URI |
024 | 7 | a https://doi.org/10.1161/ATVBAHA.115.3068492 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Madder, Ryan Du Spectrum Health System4 aut |
245 | 1 0 | a Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment-Elevation Myocardial Infarction. |
264 | 1 | c 2016 |
520 | a In a previous exploratory analysis, intracoronary near-infrared spectroscopy (NIRS) found the majority of culprit lesions in ST-segment-elevation myocardial infarction (STEMI) to contain a maximum lipid core burden index in 4 mm (maxLCBI4mm) of >400. This initial study was limited by a small sample size, enrollment at a single center, and post hoc selection of the maxLCBI4mm ≥400 threshold. This study was designed a priori to substantiate the ability of NIRS to discriminate STEMI culprit from nonculprit segments and to confirm the performance of the maxLCBI4mm ≥400 threshold. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Radiologi och bildbehandling0 (SwePub)302082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Radiology, Nuclear Medicine and Medical Imaging0 (SwePub)302082 hsv//eng |
700 | 1 | a Puri, Rishiu Cleveland Clinic Foundation4 aut |
700 | 1 | a Muller, James Eu Infraredx Inc4 aut |
700 | 1 | a Harnek, Janu Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)drad-jha |
700 | 1 | a Götberg, Matthiasu Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)kard-mgo |
700 | 1 | a VanOosterhout, Stacieu Spectrum Health System4 aut |
700 | 1 | a Chi, Margaretu Spectrum Health System4 aut |
700 | 1 | a Wohns, Davidu Spectrum Health System4 aut |
700 | 1 | a McNamara, Richardu Spectrum Health System4 aut |
700 | 1 | a Wolski, Kathyu Cleveland Clinic Foundation4 aut |
700 | 1 | a Madden, Seanu Infraredx Inc4 aut |
700 | 1 | a Sidharta, Samuelu University of Adelaide4 aut |
700 | 1 | a Andrews, Jordanu University of Adelaide4 aut |
700 | 1 | a Nicholls, Stephen Ju University of Adelaide4 aut |
700 | 1 | a Erlinge, Davidu Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)kard-der |
710 | 2 | a Spectrum Health Systemb Cleveland Clinic Foundation4 org |
773 | 0 | t Arteriosclerosis, Thrombosis and Vascular Biologyg 36:5, s. 1010-1015q 36:5<1010-1015x 1524-4636 |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/26941016?dopt=Abstracty FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1161/ATVBAHA.115.306849y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/8856269 |
856 | 4 8 | u https://doi.org/10.1161/ATVBAHA.115.306849 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view